Optiscan Imaging (ASX: OIL) — Perfil da empresa, notícias e dados financeiros
Optiscan Imaging develops high-resolution optical imaging systems, focusing on eye diseases and point-of-care solutions.
Optiscan Imaging
Optiscan Imaging is a medical technology company that develops and commercializes miniaturized confocal chromo-endomicroscopy platforms for live, single-cell digital microscopic imaging. The technology enables biopsy-free, slide-free, non-invasive, and non-destructive real-time visualization of sub-cellular structures during clinical, surgical, and veterinary procedures. Designed for applications in digital pathology, precision surgery, oral health screening, and life science research, its imaging platforms allow clinicians and researchers to analyze tissue architecture in real time. The company operates research, development, and manufacturing facilities in Australia while partnering with global medical technology companies, research institutions, and healthcare providers to integrate its technology into surgical workflows.
Resumo
Operações
Produtos e/ou serviços de Optiscan Imaging
- Surgical microscopic imaging: Handheld digital microscopic probes designed for real-time intraoperative margin assessment in breast cancer and head and neck surgeries, enabling instantaneous sub-cellular visualization during surgical procedures without requiring tissue resection or frozen section histology.
- Point-of-care digital pathology: Compact slide-free microscopic devices for benchtop and bedside tissue analysis, delivering immediate high-resolution digital cellular imaging in clinical research settings, pathology laboratories, and diagnostic clinical trial environments.
- Pre-clinical life science imaging: In vivo microscopic imaging platforms tailored for life science research and academic institutions, facilitating real-time cellular dynamic tracking, drug development studies, and non-destructive tissue analysis in animal models.
- Veterinary diagnostic endomicroscopy: Specialized sub-cellular imaging devices engineered for veterinary oncology and clinical diagnostics, providing animal health practitioners with real-time microscopic visual assessments during veterinary surgical interventions and pathology consultations across North America.
- Clinical mucosal imaging: Non-invasive mucosal imaging devices configured for screening and monitoring oral mucosal lesions and early-stage carcinomas, providing dental and head-and-neck specialists with live single-cell visualization of oral tissues.
- OEM co-developed neurosurgical systems: Micro-imaging technology platforms co-developed and manufactured under original equipment manufacturer partnerships with global medical technology companies, integrated into specialized neurosurgical microscopic systems for real-time brain tissue analysis.
equipe executiva do Optiscan Imaging
- Camile FarahCEO, MD & Executive Director
- Darius OoiChief Financial Officer
- Sanchitha FernandoChief Technology Officer
- Kaylene DawsonGeneral Counsel
- Elissa C. HansenCompany Secretary
Comunicados recentes
O que a Optiscan Imaging (OIL) comunicou ao mercado, do mais recente para o mais antigo.
- Optiscan Lodges U.S. FDA 510(k) Submission for InVueFato relevante
- Optiscan Lodges U.S. FDA 510(k) Submission for InFormFato relevante
Principais indicadores financeiros
Resultados divulgados pela Optiscan Imaging, em AUD.
- Cap. de mercado
- 162,1 mi
- Receita (TTM)
- 3,6 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.0
- Dividend yield
- —
- Margem de lucro
- -193.3%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 448,8 mil | -10,6 mi | -7 mi | |
| 3,7 mi | -6,2 mi | -6,3 mi | |
| 1,2 mi | -8,4 mi | -6,1 mi | |
| 1,7 mi | -5,3 mi | -4,4 mi |